Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Coresh

Showing results (701-710 of 1,160) with videos related to

Pageof 116
Sort By:
Pediatrics|June 5, 2003
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratificationRonald J Hogg, Susan Furth, Kevin V Lemley, et al.
Journal of the American Society of Nephrology : JASN|February 10, 2016
Candidate Surrogate End Points for ESRD after AKIMorgan E Grams, Yingying Sang, Josef Coresh, et al.
Journal of the American Society of Nephrology : JASN|March 9, 2023
Alterations in the Circulating Proteome Associated with AlbuminuriaElizabeth Kiernan, Aditya Surapaneni, Linda Zhou, et al.
The Journal of Applied Laboratory Medicine|December 16, 2025
Proteomics Analysis of Plasma for Risk of Sepsis: Findings from the Atherosclerosis Risk in Communities StudyJunichi Ishigami, Xiao Hu, Pascal Schlosser, et al.
Kidney International|December 8, 2022
A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney diseaseInga Steinbrenner, Zhi Yu, Jin Jin, et al.
Plos One|January 10, 2013
Diabetes medication use and blood lactate level among participants with type 2 diabetes: the atherosclerosis risk in communities carotid MRI studyMorgana L Mongraw-Chaffin, Kunihiro Matsushita, Frederick L Brancati, et al.
Stroke|November 21, 2009
Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) studyRebecca F Gottesman, Josef Coresh, Diane J Catellier, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 12, 2013
Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT)Hiddo J Lambers Heerspink, Misghina Weldegiorgis, Lesley A Inker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 10, 2011
Inflammatory markers and risk of cerebrovascular events in patients initiating dialysisStephen M Sozio, Josef Coresh, Bernard G Jaar, et al.
Journal of the American Society of Nephrology : JASN|December 15, 2015
Past Decline Versus Current eGFR and Subsequent ESRD RiskCsaba P Kovesdy, Josef Coresh, Shoshana H Ballew, et al.
Pageof 116

Showing results (701-710 of 1,160) with videos related to

Sort By:
Pageof 116
Pediatrics|June 5, 2003
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratificationRonald J Hogg, Susan Furth, Kevin V Lemley, et al.
Journal of the American Society of Nephrology : JASN|February 10, 2016
Candidate Surrogate End Points for ESRD after AKIMorgan E Grams, Yingying Sang, Josef Coresh, et al.
Journal of the American Society of Nephrology : JASN|March 9, 2023
Alterations in the Circulating Proteome Associated with AlbuminuriaElizabeth Kiernan, Aditya Surapaneni, Linda Zhou, et al.
The Journal of Applied Laboratory Medicine|December 16, 2025
Proteomics Analysis of Plasma for Risk of Sepsis: Findings from the Atherosclerosis Risk in Communities StudyJunichi Ishigami, Xiao Hu, Pascal Schlosser, et al.
Kidney International|December 8, 2022
A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney diseaseInga Steinbrenner, Zhi Yu, Jin Jin, et al.
Plos One|January 10, 2013
Diabetes medication use and blood lactate level among participants with type 2 diabetes: the atherosclerosis risk in communities carotid MRI studyMorgana L Mongraw-Chaffin, Kunihiro Matsushita, Frederick L Brancati, et al.
Stroke|November 21, 2009
Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) studyRebecca F Gottesman, Josef Coresh, Diane J Catellier, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 12, 2013
Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT)Hiddo J Lambers Heerspink, Misghina Weldegiorgis, Lesley A Inker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 10, 2011
Inflammatory markers and risk of cerebrovascular events in patients initiating dialysisStephen M Sozio, Josef Coresh, Bernard G Jaar, et al.
Journal of the American Society of Nephrology : JASN|December 15, 2015
Past Decline Versus Current eGFR and Subsequent ESRD RiskCsaba P Kovesdy, Josef Coresh, Shoshana H Ballew, et al.
Pageof 116